Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v10-FR Version v5-EN
Language French English
Date Updated 2021-10-14 2020-05-02
Drug Identification Number 02230451 02230451
Brand name MITOMYCIN FOR INJECTION MITOMYCIN FOR INJECTION
Common or Proper name MITOMYCIN MITOMYCIN
Company Name TEVA CANADA LIMITED TEVA CANADA LIMITED
Ingredients MITOMYCIN MITOMYCIN
Strength(s) 20MG 20MG
Dosage form(s) POWDER FOR SOLUTION POWDER FOR SOLUTION
Route of administration INTRAVENOUS INTRAVESICAL INTRAVENOUS INTRAVESICAL
Packaging size 1 1
ATC code L01DC L01DC
ATC description CYTOTOXIC ANTIBIOTICS AND RELATED SUBSTANCES CYTOTOXIC ANTIBIOTICS AND RELATED SUBSTANCES
Reason for shortage Demand increase for the drug. Demand increase for the drug.
Anticipated start date 2020-05-01 2020-05-01
Actual start date 2020-05-01
Estimated end date Unknown Unknown
Actual end date
Shortage status Actual shortage Actual shortage
Tier 3 Status No No
Company comments Item is on suspended supply
Health Canada comments